159 related articles for article (PubMed ID: 37988371)
1. Phosphorylation of AHR by PLK1 promotes metastasis of LUAD via DIO2-TH signaling.
Li C; Allison DB; He D; Mao F; Wang X; Rychahou P; Imam IA; Kong Y; Zhang Q; Zhang Y; Liu J; Wang R; Rao X; Wu S; Evers BM; Shao Q; Wang C; Li Z; Liu X
PLoS Genet; 2023 Nov; 19(11):e1011017. PubMed ID: 37988371
[TBL] [Abstract][Full Text] [Related]
2. Phosphorylation of AHR by PLK1 promotes metastasis of LUAD via DIO2-TH signaling.
Li C; Allison DB; He D; Mao F; Wang X; Rychahou P; Imam IA; Kong Y; Zhang Q; Zhang Y; Liu J; Wang R; Rao X; Wu S; Shao Q; Wang C; Li Z; Liu X
bioRxiv; 2023 Aug; ():. PubMed ID: 37577647
[TBL] [Abstract][Full Text] [Related]
3. Defective autophagy contributes to endometrial epithelial-mesenchymal transition in intrauterine adhesions.
Zhou Z; Wang H; Zhang X; Song M; Yao S; Jiang P; Liu D; Wang Z; Lv H; Li R; Hong Y; Dai J; Hu Y; Zhao G
Autophagy; 2022 Oct; 18(10):2427-2442. PubMed ID: 35196191
[TBL] [Abstract][Full Text] [Related]
4. Integrated bioinformatics analysis reveals CDK1 and PLK1 as potential therapeutic targets of lung adenocarcinoma.
Li S; Li H; Cao Y; Geng H; Ren F; Li K; Dai C; Li N
Medicine (Baltimore); 2021 Aug; 100(32):e26474. PubMed ID: 34397869
[TBL] [Abstract][Full Text] [Related]
5. Phosphorylation of TGIF2 represents a therapeutic target that drives EMT and metastasis of lung adenocarcinoma.
Du R; Wang C; Liu J; Wang K; Dai L; Shen W
BMC Cancer; 2023 Jan; 23(1):52. PubMed ID: 36647029
[TBL] [Abstract][Full Text] [Related]
6. Active PLK1-driven metastasis is amplified by TGF-β signaling that forms a positive feedback loop in non-small cell lung cancer.
Shin SB; Jang HR; Xu R; Won JY; Yim H
Oncogene; 2020 Jan; 39(4):767-785. PubMed ID: 31548612
[TBL] [Abstract][Full Text] [Related]
7. Overexpression of RCC2 Enhances Cell Motility and Promotes Tumor Metastasis in Lung Adenocarcinoma by Inducing Epithelial-Mesenchymal Transition.
Pang B; Wu N; Guan R; Pang L; Li X; Li S; Tang L; Guo Y; Chen J; Sun D; Sun H; Dai J; Bai J; Ji G; Liu P; Liu A; Wang Q; Xiao S; Fu S; Jin Y
Clin Cancer Res; 2017 Sep; 23(18):5598-5610. PubMed ID: 28606921
[No Abstract] [Full Text] [Related]
8. RHOV promotes lung adenocarcinoma cell growth and metastasis through JNK/c-Jun pathway.
Zhang D; Jiang Q; Ge X; Shi Y; Ye T; Mi Y; Xie T; Li Q; Ye Q
Int J Biol Sci; 2021; 17(10):2622-2632. PubMed ID: 34326698
[TBL] [Abstract][Full Text] [Related]
9. Stromal iodothyronine deiodinase 2 (DIO2) promotes the growth of intestinal tumors in Apc
Kojima Y; Kondo Y; Fujishita T; Mishiro-Sato E; Kajino-Sakamoto R; Taketo MM; Aoki M
Cancer Sci; 2019 Aug; 110(8):2520-2528. PubMed ID: 31215118
[TBL] [Abstract][Full Text] [Related]
10. Cytoplasmic aryl hydrocarbon receptor regulates glycogen synthase kinase 3 beta, accelerates vimentin degradation, and suppresses epithelial-mesenchymal transition in non-small cell lung cancer cells.
Li CH; Liu CW; Tsai CH; Peng YJ; Yang YH; Liao PL; Lee CC; Cheng YW; Kang JJ
Arch Toxicol; 2017 May; 91(5):2165-2178. PubMed ID: 27752740
[TBL] [Abstract][Full Text] [Related]
11. Novel long non-coding RNA LINC02323 promotes epithelial-mesenchymal transition and metastasis via sponging miR-1343-3p in lung adenocarcinoma.
Zhang X; Du L; Han J; Li X; Wang H; Zheng G; Wang Y; Yang Y; Hu Y; Wang C
Thorac Cancer; 2020 Sep; 11(9):2506-2516. PubMed ID: 32643848
[TBL] [Abstract][Full Text] [Related]
12. SAM68 promotes tumorigenesis in lung adenocarcinoma by regulating metabolic conversion via PKM alternative splicing.
Zhu S; Chen W; Wang J; Qi L; Pan H; Feng Z; Tian D
Theranostics; 2021; 11(7):3359-3375. PubMed ID: 33537092
[No Abstract] [Full Text] [Related]
13. LDH-A promotes malignant behavior via activation of epithelial-to-mesenchymal transition in lung adenocarcinoma.
Hou XM; Yuan SQ; Zhao D; Liu XJ; Wu XA
Biosci Rep; 2019 Jan; 39(1):. PubMed ID: 30509961
[TBL] [Abstract][Full Text] [Related]
14. HCP5 is a SMAD3-responsive long non-coding RNA that promotes lung adenocarcinoma metastasis via miR-203/SNAI axis.
Jiang L; Wang R; Fang L; Ge X; Chen L; Zhou M; Zhou Y; Xiong W; Hu Y; Tang X; Li G; Li Z
Theranostics; 2019; 9(9):2460-2474. PubMed ID: 31131047
[No Abstract] [Full Text] [Related]
15. The kinase PLK1 promotes the development of
Kong Y; Allison DB; Zhang Q; He D; Li Y; Mao F; Li C; Li Z; Zhang Y; Wang J; Wang C; Brainson CF; Liu X
Sci Signal; 2022 Oct; 15(754):eabj4009. PubMed ID: 36194647
[TBL] [Abstract][Full Text] [Related]
16. STEAP1 facilitates metastasis and epithelial-mesenchymal transition of lung adenocarcinoma via the JAK2/STAT3 signaling pathway.
Huo SF; Shang WL; Yu M; Ren XP; Wen HX; Chai CY; Sun L; Hui K; Liu LH; Wei SH; Wang XX; Wang Y; Tian YX
Biosci Rep; 2020 Jun; 40(6):. PubMed ID: 32515474
[TBL] [Abstract][Full Text] [Related]
17. Polo-like kinase 1 induces epithelial-to-mesenchymal transition and promotes epithelial cell motility by activating CRAF/ERK signaling.
Wu J; Ivanov AI; Fisher PB; Fu Z
Elife; 2016 Mar; 5():. PubMed ID: 27003818
[TBL] [Abstract][Full Text] [Related]
18. Ligand independent aryl hydrocarbon receptor inhibits lung cancer cell invasion by degradation of Smad4.
Lee CC; Yang WH; Li CH; Cheng YW; Tsai CH; Kang JJ
Cancer Lett; 2016 Jul; 376(2):211-7. PubMed ID: 27060206
[TBL] [Abstract][Full Text] [Related]
19. miR-24-3p/KLF8 Signaling Axis Contributes to LUAD Metastasis by Regulating EMT.
Jing P; Xie N; Zhao N; Zhu X; Li P; Gao G; Dang H; Gu Z
J Immunol Res; 2020; 2020():4036047. PubMed ID: 32411796
[TBL] [Abstract][Full Text] [Related]
20. Epithelial-Mesenchymal Transition Predicts Polo-Like Kinase 1 Inhibitor-Mediated Apoptosis in Non-Small Cell Lung Cancer.
Ferrarotto R; Goonatilake R; Yoo SY; Tong P; Giri U; Peng S; Minna J; Girard L; Wang Y; Wang L; Li L; Diao L; Peng DH; Gibbons DL; Glisson BS; Heymach JV; Wang J; Byers LA; Johnson FM
Clin Cancer Res; 2016 Apr; 22(7):1674-1686. PubMed ID: 26597303
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
